Your browser doesn't support javascript.
loading
Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer.
Carter, Rebecca; Cheraghchi-Bashi, Azadeh; Westhorpe, Adam; Yu, Sheng; Shanneik, Yasmin; Seraia, Elena; Ouaret, Djamila; Inoue, Yasuhiro; Koch, Catherine; Wilding, Jenny; Ebner, Daniel; Ryan, Anderson J; Buffa, Francesca M; Sharma, Ricky A.
Afiliação
  • Carter R; NIHR University College London Hospitals Biomedical Research Centre, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
  • Cheraghchi-Bashi A; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford OX1 2JD, UK.
  • Westhorpe A; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford OX1 2JD, UK.
  • Yu S; NIHR University College London Hospitals Biomedical Research Centre, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
  • Shanneik Y; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford OX1 2JD, UK.
  • Seraia E; Computational Biology and Integrative Genomics, University of Oxford, Oxford OX1 2JD, UK.
  • Ouaret D; NIHR Oxford Biomedical Research Centre, Department of Oncology, University of Oxford, Oxford OX1 2JD, UK.
  • Inoue Y; NDM Research Building, Nuffield Department of Medicine, University of Oxford, Oxford OX1 2JD, UK.
  • Koch C; Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX1 2JD, UK.
  • Wilding J; Mie University, Graduate School of Medicine, Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Edobashi 2-174, Tsu, Japan.
  • Ebner D; Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USA.
  • Ryan AJ; Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX1 2JD, UK.
  • Buffa FM; Target Discovery Institute, National Phenotypic Screening Centre, Nuffield Department of Medicine, University of Oxford, Oxford OX1 2JD, UK.
  • Sharma RA; CRUK & MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX1 2JD, UK.
Cancer Biol Med ; 16(2): 234-246, 2019 May.
Article em En | MEDLINE | ID: mdl-31516745
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article